Phase 3 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have completed the full treatment period of one of three related studies (CN0120020, CN0120044, or CN0120045) without experiencing a side effect that the study doctor considered a serious safety concern.
Who may not be able to join:
- People who have a history of, or show signs of, being at significant risk of harming others, seriously harming themselves, or attempting suicide — including those who answered "Yes" to certain specific questions about suicidal thoughts on a standard safety questionnaire at the first visit (note: non-suicidal self-harm on its own does not automatically disqualify you — confirm with trial site).
- People who have any significant abnormal results from a physical check-up, measurements like heart rate or temperature, or a heart tracing (ECG) taken at the end of one of the related studies, if the study doctor believes these results could put the participant at risk.
- People whose blood pressure reading — either the top number (systolic) or the bottom number (diastolic) — is high enough to be classified as "stage 2 high blood pressure," regardless of whether they have symptoms.
- There may be additional requirements not listed here that could affect eligibility (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Number of participants with treatment emergent adverse events (TEAEs); Number of participants with adverse events of special interest (AESIs); Number of participants with serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.